Close Menu
  • Home
  • World News
  • India News
  • Business News
  • Health
  • Sports
  • Indian Diaspora In US
  • Technology
  • Bollywood
  • Education
Facebook X (Twitter) Instagram
Monday, October 5, 2026
Breaking News
  • MH WellFest Cambodia 2026 Launches a New Era for ASEAN Healthcare Collaboration
  • India Aims to Play Key Role in Facilitating Russia-Ukraine Peace Talks
  • World Bank: Corruption and Bureaucracy Drive Up Business Costs in Kenya
  • Egan-Jones Pinpoints AI’s Initial Disruption Zones: From Services to Housing and Venture Capital
  • Vimal Elaichi Controversy: FDA Chief Reports Responses from Shah Rukh Khan, Ajay Devgn, and Tiger Shroff After Two Hearings
  • China Open 2026: Novak Djokovic Surpasses Rafael Nadal with Thrilling Comeback Against Alexander Zverev
  • China Open 2026: Novak Djokovic Shatters Nadal’s Record with Thrilling Comeback Against Alexander Zverev
  • Flavio Bolsonaro Triumphs Over Lula in Brazil’s Presidential Race Opener
Facebook X (Twitter) Instagram
India Bulletin
Advertisement
  • Home
  • World News
  • India News
  • Business News
  • Health
  • Sports
  • Indian Diaspora In US
  • Technology
  • Bollywood
  • Education
India Bulletin
Home»Bollywood»Vimal Elaichi Controversy: FDA Chief Reports Responses from Shah Rukh Khan, Ajay Devgn, and Tiger Shroff After Two Hearings
Bollywood

Vimal Elaichi Controversy: FDA Chief Reports Responses from Shah Rukh Khan, Ajay Devgn, and Tiger Shroff After Two Hearings

October 5, 20262 Mins Read
Facebook Twitter Email
Share
Facebook Twitter Email



The situation involving Bollywood stars Shah Rukh Khan, Ajay Devgn, and Tiger Shroff regarding a Vimal Elaichi advertisement has intensified. Recently, Tukaram Mundhe, the Commissioner of the Maharashtra Food and Drug Administration (FDA), announced that the agency has received responses from all three actors in response to the notices they were issued.

Mundhe shared that two of the actors had requested hearings, which have now concluded. The FDA is moving forward with its investigation. “We have received responses from all three actors. Two of them requested hearings, and those were completed yesterday. We are now proceeding with the next steps,” Mundhe stated.

In August 2026, the FDA issued show-cause notices to the trio related to their participation in the Vimal Elaichi advertisement that was launched in 2024. The authorities expressed concerns that the ad could be seen as a method of surrogate advertising for Vimal Pan Masala, a product mainly associated with the brand. They claimed the advertisement blurs the line between Vimal Elaichi, promoted as a mouth freshener, and the banned pan masala product.

The notices, sent on August 11, required the actors to respond within 15 days. They were also instructed to halt their involvement in the advertising campaign and remove related content from their social media and other platforms.

The FDA wanted clarity on the actors’ roles in the advertisement, including details of their endorsement contracts and any precautions taken prior to their involvement in the campaign. The agency questioned whether Vimal Elaichi was a standalone product or if its branding correlated with the prohibited Vimal Pan Masala.

With its action taken in accordance with food safety and advertising regulations, the FDA highlighted its stance that the advertising raises potential issues surrounding the indirect promotion of a banned product.

The developments in this case reflect the ongoing scrutiny of celebrity endorsements, particularly in advertising related to products under regulatory restrictions.

Ajay Devgn Controversy fda Maharashtra Food and Drug Administration Maharashtra Food and Drug Administration (FDA) News Shah Rukh Khan Tiger Shroff Tukaram Mundhe Vimal Elaichi Vimal Elaichi controversy
Share. Facebook Twitter Email
admin
  • Website

Related Posts

Vashu Bhagnani Admitted to London Hospital as Income Tax Raids Hit 12 Sites Tied to Him, Rakul Preet Singh, and Panorama Studios: Report

October 4, 2026

Microdramas Shine Bright with Kusha Kapila, Sheeba Chadha, Nikki Tamboli, and Vishal Aditya Singh!

October 4, 2026

BREAKING: CBFC Demands 45-50 Edits for TV Premiere of Dhurandhar The Revenge; U/A 16+ Cut Shrinks by 10 Minutes!

October 4, 2026
  • Facebook
  • Twitter
  • Instagram
Don't Miss

MH WellFest Cambodia 2026 Launches a New Era for ASEAN Healthcare Collaboration

India Aims to Play Key Role in Facilitating Russia-Ukraine Peace Talks

World Bank: Corruption and Bureaucracy Drive Up Business Costs in Kenya

Egan-Jones Pinpoints AI’s Initial Disruption Zones: From Services to Housing and Venture Capital

Started in 2004, India Bulletin is the largest and
most read South Asian publication
in Chicago and surrounding Midwest.

  • Home
  • About Us
  • Contact
  • Advertise With Us
  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • CCPA
News
  • Bollywood
  • Business News
  • Health
  • India News
  • Indian Diaspora In US
  • Sports
  • Technology
  • World News
Facebook X (Twitter) Instagram

Type above and press Enter to search. Press Esc to cancel.

Accessibility Adjustments

Powered by OneTap

How long do you want to hide the toolbar?
Hide Toolbar Duration
Select your accessibility profile
Vision Impaired Mode
Enhances website's visuals
Seizure Safe Profile
Clear flashes & reduces color
ADHD Friendly Mode
Focused browsing, distraction-free
Blindness Mode
Reduces distractions, improves focus
Epilepsy Safe Mode
Dims colors and stops blinking
Content Modules
Font Size

Default

Line Height

Default

Color Modules
Orientation Modules